Anfield Energy Provides 2022 Corporate Review and Plans for 2023

Jan 9, 2023

VANCOUVER, British Columbia, Jan. 09, 2023 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to provide a corporate review of 2022 and discuss its 2023 plans. Anfield continues its advance towards becoming a...

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Jan 5, 2023

TORONTO, Jan. 05, 2023 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced...

Anfield to Acquire Marysvale and Calf Mesa Uranium Projects in Utah

Jan 3, 2023

VANCOUVER, British Columbia, Jan. 03, 2023 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has entered into a definitive agreement with Nedeel LLC & BBL-2 LLC (“the Sellers”) to...

Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Dec 22, 2022

TORONTO, Dec. 22, 2022 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced...

Anfield Commissions Precision Systems Engineering to Develop Reactivation Plan for Shootaring Canyon Mill

Nov 29, 2022

VANCOUVER, British Columbia, Nov. 29, 2022 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has commissioned Precision Systems Engineering (“PSE”), a Utah-based engineering firm, to...